A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation

Bone Marrow Transplantation
Sharon EladReuven Or

Abstract

The aim of this study was to evaluate the safety, tolerability and efficacy of a topical gel containing histamine dihydrochloride (HDC) versus a placebo gel in preventing oral mucositis in hematopoietic stem cell transplantation (HSCT) patients. A total of 45 patients post-HSCT were enrolled in a prospective longitudinal, placebo-controlled, double-blind study. Patients were evaluated twice weekly for oral mucositis (OMAS, NCI score), oral pain (VAS), oral function and salivary flow rate. Compliance was assessed using a patient diary. Oral mucositis developed in 85% of the HDC group and 63% of the placebo group. The mean maximal intensity for NCI score was 1.45+/-1 in the HDC group and 1.21+/-1.27 in the placebo group (P=0.37). The mean duration of oral mucositis was 4.7+/-3.6 and 2.33+/-2.23 days in the HDC and placebo groups, respectively (P=0.06). The same trends were measured with OMAS. Visual analogue scale for oral pain and oral function was not significantly different between the two groups. Histamine dihydrochloride was found to be safe. In the search for topical agents for the prevention of mucositis, we found that HDC neither improves nor worsens oral mucositis in HSCT patients. The balance between the pro- and anti-i...Continue Reading

References

Feb 1, 1995·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·G ChaushuA A Garfunkel
Sep 22, 1998·Acta Oncologica·K HellstrandM Brune
Jan 29, 2000·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·L A BellmH J Fuchs
Mar 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J SiroisE Y Bissonnette
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S T SonisM Horowitz
Aug 24, 2002·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Joel B EpsteinJonathan A Ship
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neal J MeropolLee S Rosen
Mar 25, 2004·Seminars in Oncology Nursing·Joel B Epstein, Mark M Schubert
Apr 27, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Joel B EpsteinJoshua D Epstein
Apr 27, 2004·Cancer·Stephen T SonisUNKNOWN International Society for Oral Oncology
Apr 27, 2004·Cancer·Edward B RubensteinUNKNOWN International Society for Oral Oncology
Nov 30, 2004·Dental Clinics of North America·Rajesh V Lalla, Douglas E Peterson
Dec 17, 2004·The New England Journal of Medicine·Ricardo SpielbergerChristos Emmanouilides
Apr 16, 2005·International Archives of Allergy and Immunology·Marek JutelCezmi A Akdis

❮ Previous
Next ❯

Citations

Aug 6, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Velia Ramírez-AmadorSergio Ponce-de-León
Sep 25, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Cesar MiglioratiUNKNOWN Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (
May 25, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ourania Nicolatou-GalitisUNKNOWN Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (
Nov 19, 2010·Expert Review of Hematology·Pasquale Niscola
Apr 11, 2018·Oral Diseases·Sjm van LeeuwenMcDnjm Huysmans
Apr 15, 2011·The Cochrane Database of Systematic Reviews·Helen V WorthingtonTasneem Khalid
Sep 28, 2017·Journal of Clinical Pharmacy and Therapeutics·V Ramírez-AmadorS Ponce de León-Rosales

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.